Outlook Therapeutics, Inc.
DE ˙ DB
0,75 € ↑0,07 (11,08%)
2026-06-04
DELAT PRIS
SecurityDE:41O / Outlook Therapeutics, Inc.
InstitutionVanguard Group Inc
Latest Disclosed Ownership1,465,167 shares
Latest Disclosed Value $ 2,314,964
Vanguard Group Inc reports 9.13% increase in ownership of 41O / Outlook Therapeutics, Inc.

On January 29, 2026 - Vanguard Group Inc filed a 13F-HR form disclosing ownership of 1,465,167 shares of Outlook Therapeutics, Inc. (DE:41O) valued at $2,402,874 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 7, 2025 disclosing 1,342,627 shares of Outlook Therapeutics, Inc.. This represents a change in shares of 9.13% during the quarter. The current value of the position is $1,101,806 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-01-29 2025-12-31 13F OUTLOOK THERAPEUTICS COM 69012T305 1,465,167 122,540 9.13 2,315 62.61 0.0000
2025-11-07 2025-09-30 13F OUTLOOK THERAPEUTICS COM 69012T305 1,342,627 91,029 7.27 1,423 -28.92 0.0000
2025-08-11 2025-06-30 13F OUTLOOK THERAPEUTICS COM 69012T305 1,251,598 414,191 49.46 2,003 96.08 0.0000
2025-05-09 2025-03-31 13F OUTLOOK THERAPEUTICS COM 69012T305 837,407 -15,133 -1.78 1,022 -36.62 0.0000
2025-02-11 2024-12-31 13F OUTLOOK THERAPEUTICS COM 69012T305 852,540 -3,336 -0.39 1,611 -64.75 0.0000
2024-11-13 2024-09-30 13F OUTLOOK THERAPEUTICS COM 69012T305 855,876 308,103 56.25 4,570 13.06 0.0001
2024-08-13 2024-06-30 13F OUTLOOK THERAPEUTICS COM 69012T305 547,773 206,473 60.50 4,043 -0.81 0.0001
2024-05-10 2024-03-31 13F OUTLOOK THERAPEUTICS COM 69012T305 341,300 -231,505 -40.42 4,075 626.38 0.0001
2018-12-13 2018-09-30 13F/A-2 ONCOBIOLOGICS COM 68235M105 572,805 263,768 85.35 561 114.94 0.0000
2018-11-23 2018-09-30 13F/A-1 ONCOBIOLOGICS COM 68235M105 572,805 0 561 0.0000
2018-11-14 2018-09-30 13F ONCOBIOLOGICS COM 68235M105 572,805 263,768 561
2018-08-14 2018-06-30 13F ONCOBIOLOGICS COM 68235M105 309,037 -3,670 -1.17 261 -6.12 0.0000
2018-05-15 2018-03-31 13F ONCOBIOLOGICS COM 68235M105 312,707 7,440 2.44 278 -29.97 0.0000
2018-02-14 2017-12-31 13F ONCOBIOLOGICS COM 68235M105 305,267 0 0.00 397 -5.02 0.0000
2017-11-14 2017-09-30 13F ONCOBIOLOGICS COM 68235M105 305,267 22,527 7.97 418 46.67 0.0000
2017-08-24 2017-06-30 13F/A-1 ONCOBIOLOGICS COM 68235M105 282,740 0 0.00 285 -62.35 0.0000
2017-08-11 2017-06-30 13F ONCOBIOLOGICS COM 68235M105 282,740 0 285
2017-05-12 2017-03-31 13F ONCOBIOLOGICS COM 68235M105 282,740 3,467 1.24 757 -9.99 0.0000
2017-02-14 2016-12-31 13F ONCOBIOLOGICS COM 68235M105 279,273 186,158 199.92 841 112.37 0.0000
2016-11-14 2016-09-30 13F ONCOBIOLOGICS COM 68235M105 93,115 93,115 396 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.